His Gene Therapy Near Approval, Spark CEO Wonders: What Price Vision? – Xconomy
XconomyHis Gene Therapy Near Approval, Spark CEO Wonders: What Price Vision?XconomyPerhaps this year, Spark Therapeutics could be the first ever in the U.S. to win approval of a gene therapy with its one-time treatment for an inherited form of blindnes… Continue reading
